Nidaa A Ababneh Selected Research

Type 2A2 Axonal Charcot-Marie-Tooth Disease

1/2022

Generation of a human induced pluripotent stem cell (iPSC) line (JUCTCi019-A) from a patient with Charcot-Marie-Tooth disease type 2A2 (CMT2A2) due to a heterozygous missense substitution c.2119C > T (p.Arg707Trp) in MFN2 gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nidaa A Ababneh Research Topics

Disease

2	COVID-19 01/2021 - 01/2020
1	Type 2A2 Axonal Charcot-Marie-Tooth Disease 01/2022
1	Chronic Disease (Chronic Diseases) 01/2021
1	Infertility (Sterility) 01/2021
1	Neoplasms (Cancer) 12/2020
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 07/2020
1	Cerebellar Ataxia (Dysmetria) 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Infections 01/2019

Drug/Important Bio-Agent (IBA)

2	VaccinesIBA 01/2021 - 01/2020
1	Pharmaceutical PreparationsIBA 01/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 12/2020
1	Cholinergic ReceptorsIBA 07/2020
1	Therapeutic UsesIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2020

Therapy/Procedure

2	Therapeutics 12/2020 - 01/2019